Trial Profile

RCT Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone (REST)

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 26 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Trazodone (Primary)
Indications Alzheimer's disease; Mild cognitive impairment; Sleep disorders
Focus Therapeutic Use
Acronyms REST

Most Recent Events

11 Sep 2024 Planned End Date changed from 1 May 2028 to 30 Jun 2028.
11 Sep 2024 Planned primary completion date changed from 1 Mar 2027 to 30 Jul 2027.
05 Jan 2023 Planned initiation date changed from 20 Nov 2022 to 4 Jan 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com